China Cash Squeeze Rolls on Even After Central Bank’s Infusions.

China’s cash squeeze extended with some signs of disruption to trading, as a liquidity infusion from Beijing failed to counteract a spike in demand for funds.

The volume-weighted average rate of seven-day repurchase transactions in the money market, a gauge of borrowing costs, climbed to 2.32%, the highest since October 2023.

he People’s Bank of China injected another 336.4 billion yuan ($45.9 billion) of short-term funds into the banking system on Thursday.

Source: FINANCE